STN: 125611 Proper Name: Coagulation Factor IX (Recombinant), GlycoPEGylated Tradename: REBINYN Manufacturer: Novo Nordisk Inc. Indication:
Is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B for: (1) On-demand treatment and control of bleeding episodes; (2) Perioperative management of bleeding.
Product Information
Supporting Documents
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
